CompletedNCT04711460
This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Global
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
CompletedNCT06231407
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Schizophrenia
Not Yet RecruitingNCT06208176
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Schizophrenia
CompletedNCT03355781
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
CompletedNCT06206798
This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 20 Years to 64 Years
- Countries
- Taiwan
- Sponsor
- National Taipei University of Nursing and Health Sciences
- Condition
- Schizophrenia
CompletedNCT03309475
This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- Spain
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz
- Condition
- Schizophrenia
CompletedNCT05304780
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 20 Years to 64 Years
- Countries
- Taiwan
- Sponsor
- National Taipei University of Nursing and Health Sciences
- Condition
- Schizophrenia
CompletedNCT06190483
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
Not Yet RecruitingNCT06184165
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- Global
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
CompletedNCT04158687
This study exists to understand whether the medication CTP-692 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication CTP-692 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Concert Pharmaceuticals
- Condition
- Schizophrenia
CompletedNCT03198078
This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
SchizophreniaOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
TerminatedNCT06012981
This study exists to improve how acceptance and commitment therapy, a talking treatment, can help identify, measure, or follow care over time. Researchers are trying to understand what acceptance and commitment therapy, a talking treatment, could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- Sweden
- Sponsor
- Uppsala University
- Condition
- Schizophrenia
TerminatedNCT03318640
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
CompletedNCT04659161
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
WithdrawnNCT03271814
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 15 Years to 55 Years
- Countries
- Global
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT04783246
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Boston Medical Center
- Condition
- Schizophrenia
CompletedNCT04546178
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherFrom 19 Years to 35 Years
- Countries
- Canada
- Sponsor
- Nova Scotia Health Authority
- Condition
- Schizophrenia
TerminatedNCT04203056
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
CompletedNCT01481883
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- Australia
- Sponsor
- The Alfred
- Condition
- Schizophrenia
Not Yet RecruitingNCT03543553
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 17 Years to 55 Years
- Countries
- Global
- Sponsor
- Oslo University Hospital
- Condition
- Schizophrenia
CompletedNCT02823041
This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
RecruitingNCT05956327
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Germany
- Sponsor
- LMU Klinikum
- Condition
- Schizophrenia
CompletedNCT03859973
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Australia, Canada, France, New Zealand, United Kingdom, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT05633108
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Eisai Co., Ltd.
- Condition
- Schizophrenia
CompletedNCT04442893
This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 20 Years to 65 Years
- Countries
- Taiwan
- Sponsor
- National Yang Ming Chiao Tung University
- Condition
- Schizophrenia